Vistagen Therapeutics, Inc. (VTGN)

0.6342 -0.01 (-1.70%) USD  |  NASDAQ  |  Jan 21, 16:00
0.649 +0.01 (+2.33%) Pre-Market: 08:15
More

Vistagen Therapeutics Stock Based Compensation (Quarterly)

Stock Based Compensation (Quarterly) Chart

View Stock Based Compensation (Quarterly) for VTGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Quarterly) Range, Past 5 Years

View Stock Based Compensation (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Quarterly) Benchmarks

View Stock Based Compensation (Quarterly) Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. Upgrade
XOMA Royalty Corp. Upgrade
Omeros Corp. Upgrade
GeoVax Labs, Inc. Upgrade
Daré Bioscience, Inc. Upgrade